- Home
- BMY vs MMM Comparison
BMY vs MMM Comparison
Compare BMY & MMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- MMM
- Stock Information
- Founded
- BMY 1887
- MMM 1902
- Country
- BMY United States
- MMM United States
- Employees
- BMY N/A
- MMM N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- MMM Medical/Dental Instruments
- Sector
- BMY Health Care
- MMM Health Care
- Exchange
- BMY Nasdaq
- MMM Nasdaq
- Market Cap
- BMY 97.6B
- MMM 79.7B
- IPO Year
- BMY N/A
- MMM N/A
- Fundamental
- Price
- BMY $46.50
- MMM $151.44
- Analyst Decision
- BMY Hold
- MMM Buy
- Analyst Count
- BMY 16
- MMM 13
- Target Price
- BMY $58.33
- MMM $151.23
- AVG Volume (30 Days)
- BMY 13.5M
- MMM 2.7M
- Earning Date
- BMY 07-31-2025
- MMM 07-25-2025
- Dividend Yield
- BMY 5.35%
- MMM 1.92%
- EPS Growth
- BMY N/A
- MMM N/A
- EPS
- BMY 2.67
- MMM 7.93
- Revenue
- BMY $47,636,000,000.00
- MMM $24,513,000,000.00
- Revenue This Year
- BMY N/A
- MMM N/A
- Revenue Next Year
- BMY N/A
- MMM $2.99
- P/E Ratio
- BMY $17.36
- MMM $19.20
- Revenue Growth
- BMY 4.62
- MMM N/A
- 52 Week Low
- BMY $39.35
- MMM $98.26
- 52 Week High
- BMY $63.33
- MMM $156.35
- Technical
- Relative Strength Index (RSI)
- BMY 39.67
- MMM 58.65
- Support Level
- BMY $46.18
- MMM $147.12
- Resistance Level
- BMY $47.07
- MMM $150.29
- Average True Range (ATR)
- BMY 0.85
- MMM 2.86
- MACD
- BMY -0.18
- MMM 0.43
- Stochastic Oscillator
- BMY 7.18
- MMM 96.54
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MMM 3M Company
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.